Patents Assigned to SmithKline Beechan Corporation
  • Substituted anilinopyrazoles
    Patent number: 7507834
    Abstract: The present invention relates to anilinopyrazole derivatives, methods for the preparation of such anilinopyrazoles, and use of such anilinopyrazoles in the treatment of certain diseases or conditions. In particular, the present invention relates to a nilinopyrazole derivatives useful as CDK2 inhibitors and use of the anilinopyrazoles in the treatment of disorders mediated by inappropriate CDK2 activity.
    Type: Grant
    Filed: February 25, 2004
    Date of Patent: March 24, 2009
    Assignee: SmithKline Beechan Corporation
    Inventor: Jun Tang
  • Chemical compounds
    Patent number: 6951861
    Abstract: The invention relates to piperazine derivatives, to processes for their preparation, to pharmaceutical compositions containing them, and to their medical use. The novel compounds are antagonists of tachykinins, including substance P and other neurokinins.
    Type: Grant
    Filed: October 5, 2000
    Date of Patent: October 4, 2005
    Assignee: SmithKline Beechan Corporation
    Inventors: Giuseppe Alvaro, Romano Di Fabio, Riccardo Giovannini, Giuseppe Guercio, Yves St-Denis, Antonella Ursini, Mauro Corsi, Sergio Melotto